| [1] |
Anderson EJ, Campbell JD, Creech CB, et al.Warp speed for COVID-19 vaccines: why are children stuck in neutral? Clin Infect Dis, 2020, DOI:10.1093/cid/ciaa1425
|
| [2] |
Lazarus JV, Picchio CA, Nayagam S, et al.Strengthening vaccine confidence during the COVID-19 pandemic: A new opportunity for global hepatitis B virus elimination.J Hepatol, 2020,73(3):490-492.
|
| [3] |
Marrone R, Baglio G, Bruscino G, et al.Prevalence of latent tuberculosis infection, hepatitis B, hepatitis C, and syphilis among newly arrived unaccompanied minors living in reception centers in Rome.Int J Infect Dis, 2020, DOI:10.1016/ j.ijid. 2020.09.020
|
| [4] |
Nayagam S, Shimakawa Y, Lemoine M.Mother-to-child transmission of Gavi supported countries. Available at: https://www.gavi.org/ programmes-impact/country-hub.
|
| [5] |
A two-dose hepatitis B vaccine for adults (Heplisav-B). Med Lett Drugs Ther, 2018, 60(1539)
|
| [6] |
Hepatitis B: what more needs to be done to eliminate it around the world? J Hepatol, 2020, 27: 342-349
|
| [7] |
World Health Organization.Global Health Sector Strategy (GHSS) on viral hepatitis. Geneva, Switzerland: WHO, 2016-2021
|
| [8] |
World Health Organization.Ten threats to global health in 2019. Available at: www. who. int/ news-room/feature-stories/ten-threats-to-global-health-in-2019
|
| [9] |
World Health Organization. Global Hepatitis Report2017. 2017, Available at: https: //apps.who.int/iris/bitstream/handle/10665/255016/97892415 65455-eng.pdf?sequence=1
|
| [10] |
Hogan A, Jewell B, Sherrard-Smith E, et al.Report 19-the potential impact of the COVID-19 epidemic on HIV, TB, and malaria in low-and middle-income countries. London: Imperial College London,2020.
|
| [11] |
World Health Organization. Protecting lifesaving immunization services during COVID-19: new guidance from WHO.2020. Available at: https:// www. who. int/immunization /news_guidance_immunization_services_during_COVID-19/en/
|
| [12] |
The COVID-19 vaccine development landscape. Nature reviews.2020. Available at: https:// www. nature.com/articles/d41573-020-00073-5
|
| [13] |
Li AY, Liu Z, Song Y, et al.Reduction of the occurrence of occult HBV infection in infants by increasing the dose of hepatitis B vaccine: a large prospective cohort study. Emerg Microbes Infect, 2020, 9:1881-1891
|
| [14] |
Wingrove C, Ferrier L, James C, et al.The impact of COVID-19 on hepatitis elimination. Lancet Gastroenterol Hepatol, 2020, 5:792-794.
|
| [15] |
Nayagam S, Thursz M, Sicuri E, et al.Requirements for global elimination of hepatitis B: a modelling study.Lancet Infect Dis, 2016,16: 1399-1408.
|
